Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Current Deferred Revenue (2024 - 2025)

Incannex Healthcare's Current Deferred Revenue history spans 2 years, with the latest figure at $30000.0 for Q4 2025.

  • For Q4 2025, Current Deferred Revenue rose 11.11% year-over-year to $30000.0; the TTM value through Dec 2025 reached $30000.0, up 11.11%, while the annual FY2025 figure was $30000.0, 64.71% down from the prior year.
  • Current Deferred Revenue for Q4 2025 was $30000.0 at Incannex Healthcare, roughly flat from $30000.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $85000.0 in Q2 2024 and bottomed at $27000.0 in Q4 2024.